Ahead of print

Case report

Anterior Chamber Cholesterolosis in a 1-Year-Old Patient with Coats’ Disease. A Case Report

Full Text links

Summary

Aim: To present a rare case of anterior chamber cholesterolosis in a patient with Coats’ disease with emphasis on the differential diagnosis, to compare the clinical findings and therapeutic approach with previously reported cases; and to clarify the pathogenetic mechanisms and associated complications of anterior chamber cholesterolosis, based on an analogy with previously published cases.

Case report: A 14-month-old boy was brought to our clinic with a painful, irritated right eye. Anterior chamber cholesterolosis was identified, associated with acute glaucoma, total retinal detachment, and vitreous hyperechogenicity with suspected calcifications on ultrasound (US). Coats’ disease with anterior chamber cholesterolosis or retinoblastoma-associated masquerade syndrome were considered in the differential diagnosis. Magnetic resonance imaging (MRI) did not confirm retinoblastoma. The patient underwent anterior chamber lavage, followed by intracameral and intravitreal injection of an anti-vascular endothelial growth factor (anti-VEGF) agent. A cytological analysis of the anterior chamber aspirate showed no evidence of malignant cells. Although the treatment achieved the expected effect, the eye gradually progressed to phthisis bulbi. Nevertheless, the eye has remained painless, it has shown no signs of irritation and the intraocular condition has remained stable over the long term.

Conclusion: Anterior chamber cholesterolosis is a rare complication of Coats’ disease, reported in less than 3% of patients. Exclusion of retinoblastoma-associated masquerade syndrome is essential in the differential diagnosis. In comparison with previously published cases of anterior chamber cholesterolosis as a complicating factor in Coats’ disease, we have observed a similar character and course of the disease in patients with onset in early childhood. However, a difference can be observed in the therapeutic approach. In all the previously reported cases, the painful eye was enucleated. In our case, preserving the blind eye through a more conservative surgical approach proved beneficial.

References

  1. Sen M, Shields CL, Honavar SG, et al. Coats disease: An overview of classification, management and outcomes. Indian J Ophthalmol. 2019 Jan 06;67(6):763.
  2. Dalvin LA, Udyaver S, Lim LAS, Mazloumi M, et al. Coats Disease: Clinical Features and Outcomes by Age Category in 351 Cases. J Pediatr Ophthalmol Strabismus. 2019 Sep;56(5):288-296.
  3. Jeng-Miller KW, Soomro T, Scott NL, et al. Longitudinal Examination of Fellow-Eye Vascular Anomalies in Coats’ Disease With Widefield Fluorescein Angiography: A Multicenter Study. Ophthalmic Surg Las Imag Ret. 2019 Apr 01;50(4):221-227.
  4. Shields CL, Udyaver S, Dalvin LA, et al. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center. Indian J Ophthalmol. 2019 Jun;67(6):772-783.
  5. Characteristics and Management of Coats Disease [Internet]. American Academy of Ophthalmology. 2017 [cit 01. marec 2025]. Available from: https://www.aao.org/eyenet/article/characteristics-management-of-coats-disease
  6. Shields JA, Eagle RC, Fammartino J, et al. Coats’ disease as a cause of anterior chamber cholesterolosis. Arch Ophthalmol Chic Ill 1960. 1995 Aug;113(8):975-977.
  7. Stacey AW, Borri M, Francesco SD, et al. A Case of Anterior Chamber Cholesterolosis Due to Coats’ Disease and a Review of Reported Cases. Open Ophthalmol J. 2016 Feb 29;10:27-32.
  8. Gupta N, Beri S, D’souza P. Cholesterolosis Bulbi of the Anterior Chamber in Coats Disease. J Pediatr Ophthalmol Strabismus. 2009 Jun 25.
  9. Patel AK, Murphy M, Shields CL. Picture of the month: anterior chamber cholesterolosis in Coats disease. Arch Pediatr Adolesc Med. 2011 Dec;165(12):1131-1132.
  10. Shields JA, Shields CL, Honavar SG, et al. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol. 2001 May 01;131(5):561-571.
  11. Shields JA, Shields CL, Honavar SG, et al. Classification and management of Coats disease: the 2000 Proctor Lecture. Am J Ophthalmol. 2001 May;131(5):572-583.
  12. Daruich AL, Moulin AP, Tran HV, et al. Subfoveal nodule in Coats disease. Retina Phila Pa. 2017 Aug;37(8):1591-1598.
  13. Gupta A, Paulbuddhe VS, Shukla UV, et al. Exudative Retinitis (Coats Disease). V: StatPearls [Internet]. Treasure Island (FL): Stat- Pearls Publishing; 2025 [cit 29. máj 2025]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK560682/
  14. Hong BK, Say EAT, Chévez-Barrios P, et al. Anterior chamber cholesterolosis in a patient with retinoblastoma. Digit J Ophthalmol. 2016 Mar 31;22(1):35-37.
  15. He YG, Wang H, Zhao B, et al. Elevated vascular endothelial growth factor level in Coats’ disease and possible therapeutic role of bevacizumab. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2010 Okt;248(10):1519-1521.
  16. Bai J, Song Z, Li G, et al. Efficacy and Safety of Anti-Vascular Endothelial Growth Factor Drugs for Coats’ Disease Treatment: A Systematic Review. J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther. 2023 Sep;39(7):418-429.
  17. Zhao Q, Peng XY, Chen FH, et al. Vascular endothelial growth factor in Coats’ disease. Acta Ophthalmol (Copenh). 2014 May;92(3):e225-228.
  18. Pavlíková K, Krejčířová I, Autrata R, et al. Choroidal Neovascular Membrane in Pediatric Patients: Long-Term Outcomes of Anti-VEGF Therapy. Cesk Slov Oftalmol. Ahead of print. 2025 Aug 20. Available from: https://www.cs-ophthalmology.cz/cs/journal/articles/379